NSD2 is a conserved driver of metastatic prostate cancer progression
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
NSD2 is a conserved driver of metastatic prostate cancer progression
Authors
Keywords
-
Journal
Nature Communications
Volume 9, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-11-30
DOI
10.1038/s41467-018-07511-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Evolutionary Landscape of Localized Prostate Cancers Drives Clinical Aggression
- (2018) Shadrielle Melijah G. Espiritu et al. CELL
- Structural Alterations Driving Castration-Resistant Prostate Cancer Revealed by Linked-Read Genome Sequencing
- (2018) Srinivas R. Viswanathan et al. CELL
- Characterization of H3.3K36M as a tool to study H3K36 methylation in cancer cells
- (2017) Saumya M. Sankaran et al. Epigenetics
- AKT-mediated stabilization of histone methyltransferase WHSC1 promotes prostate cancer metastasis
- (2017) Ni Li et al. JOURNAL OF CLINICAL INVESTIGATION
- Genomic hallmarks of localized, non-indolent prostate cancer
- (2017) Michael Fraser et al. NATURE
- Emerging Variants of Castration-Resistant Prostate Cancer
- (2017) Panagiotis J. Vlachostergios et al. Current Oncology Reports
- NSD1- and NSD2-damaging mutations define a subset of laryngeal tumors with favorable prognosis
- (2017) Suraj Peri et al. Nature Communications
- BLIMP1 Induces Transient Metastatic Heterogeneity in Pancreatic Cancer
- (2017) Shin-Heng Chiou et al. Cancer Discovery
- Transdifferentiation as a Mechanism of Treatment Resistance in a Mouse Model of Castration-Resistant Prostate Cancer
- (2017) Min Zou et al. Cancer Discovery
- An Integrated Systems Biology Approach Identifies TRIM25 as a Key Determinant of Breast Cancer Metastasis
- (2017) Logan A. Walsh et al. Cell Reports
- The Role of Nuclear Receptor–Binding SET Domain Family Histone Lysine Methyltransferases in Cancer
- (2017) Richard L. Bennett et al. Cold Spring Harbor Perspectives in Medicine
- Neuroendocrine Prostate Cancer: Subtypes, Biology, and Clinical Outcomes
- (2017) Rahul Aggarwal et al. Journal of the National Comprehensive Cancer Network
- Exploiting the Epigenome to Control Cancer-Promoting Gene-Expression Programs
- (2016) Gerard L. Brien et al. CANCER CELL
- A PWWP Domain of Histone-LysineN-Methyltransferase NSD2 Binds to Dimethylated Lys-36 of Histone H3 and Regulates NSD2 Function at Chromatin
- (2016) Saumya M. Sankaran et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Meta-Analysis Evaluating the Impact of Site of Metastasis on Overall Survival in Men With Castration-Resistant Prostate Cancer
- (2016) Susan Halabi et al. JOURNAL OF CLINICAL ONCOLOGY
- Prostate cancer
- (2016) Gerhardt Attard et al. LANCET
- Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer
- (2016) Akash Kumar et al. NATURE MEDICINE
- Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer
- (2016) Himisha Beltran et al. NATURE MEDICINE
- MMSET/WHSC1 enhances DNA damage repair leading to an increase in resistance to chemotherapeutic agents
- (2016) M Y Shah et al. ONCOGENE
- NSD2 contributes to oncogenic RAS-driven transcription in lung cancer cells through long-range epigenetic activation
- (2016) Verónica García-Carpizo et al. Scientific Reports
- Epigenetic signature of Gleason score and prostate cancer recurrence after radical prostatectomy
- (2016) Milan S. Geybels et al. Clinical Epigenetics
- Integrative Clinical Genomics of Advanced Prostate Cancer
- (2015) Dan Robinson et al. CELL
- Combined Tumor Suppressor Defects Characterize Clinically Defined Aggressive Variant Prostate Cancers
- (2015) A. M. Aparicio et al. CLINICAL CANCER RESEARCH
- The evolutionary history of lethal metastatic prostate cancer
- (2015) Gunes Gundem et al. NATURE
- Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue
- (2015) Colin S Cooper et al. NATURE GENETICS
- Pancreatic Cancer Metastases Harbor Evidence of Polyclonality
- (2015) R. Maddipati et al. Cancer Discovery
- Proposed Morphologic Classification of Prostate Cancer With Neuroendocrine Differentiation
- (2014) Jonathan I. Epstein et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Cross-Species Regulatory Network Analysis Identifies a Synergistic Interaction between FOXM1 and CENPF that Drives Prostate Cancer Malignancy
- (2014) Alvaro Aytes et al. CANCER CELL
- High-risk prostate cancer—classification and therapy
- (2014) Albert J. Chang et al. Nature Reviews Clinical Oncology
- Luminal Cells Are Favored as the Cell of Origin for Prostate Cancer
- (2014) Zhu A. Wang et al. Cell Reports
- Origins of Metastatic Traits
- (2013) Sakari Vanharanta et al. CANCER CELL
- Punctuated Evolution of Prostate Cancer Genomes
- (2013) Sylvan C. Baca et al. CELL
- Global chromatin profiling reveals NSD2 mutations in pediatric acute lymphoblastic leukemia
- (2013) Jacob D Jaffe et al. NATURE GENETICS
- ETV4 promotes metastasis in response to activation of PI3-kinase and Ras signaling in a mouse model of advanced prostate cancer
- (2013) A. Aytes et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Transcriptional control of cancer metastasis
- (2013) Brian Ell et al. TRENDS IN CELL BIOLOGY
- Cancer Epigenetics: From Mechanism to Therapy
- (2012) Mark A. Dawson et al. CELL
- Characterization of the EZH2-MMSET Histone Methyltransferase Regulatory Axis in Cancer
- (2012) Irfan A. Asangani et al. MOLECULAR CELL
- The mutational landscape of lethal castration-resistant prostate cancer
- (2012) Catherine S. Grasso et al. NATURE
- Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer
- (2012) Christopher E Barbieri et al. NATURE GENETICS
- Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape
- (2012) Bradley N Bidwell et al. NATURE MEDICINE
- The histone methyltransferase MMSET/WHSC1 activates TWIST1 to promote an epithelial–mesenchymal transition and invasive properties of prostate cancer
- (2012) T Ezponda et al. ONCOGENE
- Emerging Epigenetic Targets and Therapies in Cancer Medicine
- (2012) Relja Popovic et al. Cancer Discovery
- NSD2 Links Dimethylation of Histone H3 at Lysine 36 to Oncogenic Programming
- (2011) Alex J. Kuo et al. MOLECULAR CELL
- Suppression of lung adenocarcinoma progression by Nkx2-1
- (2011) Monte M. Winslow et al. NATURE
- The genomic complexity of primary human prostate cancer
- (2011) Michael F. Berger et al. NATURE
- Molecular sampling of prostate cancer: a dilemma for predicting disease progression
- (2010) Andrea Sboner et al. BMC Medical Genomics
- Integrative Genomic Profiling of Human Prostate Cancer
- (2010) Barry S. Taylor et al. CANCER CELL
- Global Levels of Specific Histone Modifications and an Epigenetic Gene Signature Predict Prostate Cancer Progression and Development
- (2010) T. Bianco-Miotto et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Modeling metastasis in the mouse
- (2010) Paula D Bos et al. CURRENT OPINION IN PHARMACOLOGY
- The histone methyltransferase, NSD2, enhances androgen receptor-mediated transcription
- (2009) Hee-Bum Kang et al. FEBS LETTERS
- A luminal epithelial stem cell that is a cell of origin for prostate cancer
- (2009) Xi Wang et al. NATURE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started